Helicobacter pylori is a human pathogen that infects the stomach. More than half of the human population is infected with H. pylori, which is major cause of peptic ulcers, gastric cancers and mucosa-associated lymphoid tissue lymphoma. However, the majority of patients infected with H. pylori generally remain asymptomatic and never develop significant disease. H. pylori has high genetic diversity, and different genotypes of H. pylori are involved in different gastroduodenal disorders. The hosts' genetic factors also influence the development of peptic ulcers and gastric cancer, and plenty of evidence has demonstrated that genetics plays a role in susceptibility and contributes to the differences between those who develop H. pylori infection, peptic ulcers and gastric cancer. [1] [2] [3] Numerous single nucleotide polymorphism (SNP) studies have been undertaken to identify candidate genes that most likely play a role in the development of peptic ulcers and gastric cancer. [4] [5] [6] [7] [8] Recently, a genome wide association study (GWAS) and next generation sequencing study identified several genetic loci that confer susceptibility for H. pylori infection and gastroduodenal disease. 9, 10 H. pylori prevalence is as high as 90% in some countries, but approximately 5% to 10% of a given population is never infected with H. pylori, even in the presence of high exposure rates. 9 A GWAS meta-analysis identified an association between Toll-like receptor 1 (TLR1) and H. pylori seroprevalence, suggesting that genetic variations in TLR1 may explain some of the observed variations in individual risk for developing H. pylori infection. 9 The pathogenesis of different clinical outcomes is multifactorial and includes the virulence of H. pylori, environmental TNF-α plays a crucial role in the host's immunological defense against H. pylori infection. A TNF-α promoter SNP has been shown to be associated with an increased risk for the development of atrophic gastritis, peptic ulcers and gastric cancer. While the TNF-α 1031 and 863 promoter SNPs are significant risk factors for peptic ulcer in combination with H. pylori infection in Taiwan, 1 neither TNF-α 1031 nor 308 TNF-α is a risk factor for peptic ulcer after H. pylori infection in the Polish population. 10 In China, IL-B-511, IL-RN, and TNF-α 308 polymorphisms are not associated with the development of duodenal ulcers. 8 In Israel, the H. pylori iceA1 bacterial strain is associated with duodenal disease in children, and a TNF-α 238 G polymorphism has been found to be a risk factor for the development of peptic ulcers in children infected with H. pylori. 5 In Japan, polymorphisms in interferon-α, rather than IL-1β, are associated with an increased risk of developing gastric ulcers and cancer. 4 A GWAS that compared samples form duodenal ulcers and healthy controls in Japan identified two susceptible loci at the prostate stem cell antigen gene at the 8q24 and a locus at the ABO blood group gene at 9q34.
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In Korea, several studies have been undertaken to determine the role of polymorphisms in the IL-10 and TNF-α promoter genes in the development of peptic ulcers and gastric cancer. The IL-10-1082/592 and TNF-α 308 genetic polymorphisms were not found to be important risk factors for peptic ulcers and gastric cancer in Korea. 6 However, genetic polymorphisms in IL-1B and IL-1RN contribute to the development of gastric ulcers and gastric cancer after H. pylori infection. 7 H. pylori is a strong risk factor for gastric cancer. However, only a small portion of H. pylori-infected subjects eventually develop gastric cancer. Gastric carcinogenesis is affected by several factors, including the strain of H. pylori, environmental factors (smoking, high salt intake, and so forth) and host genetics. IL-10 polymorphisms (819C and 592C alleles have complete linkage disequilibrium with 819T) are associated with H. pylori infection and smoking, which increase the risk of developing noncardia gastric cancer, especially intestinal type, in Korea.
